Oncovin Interactions
There are 495 drugs known to interact with Oncovin (vincristine), along with 8 disease interactions. Of the total drug interactions, 79 are major, 389 are moderate, and 27 are minor.
- View all 495 medications that may interact with Oncovin
- View Oncovin disease interactions (8)
Most frequently checked interactions
View interaction reports for Oncovin (vincristine) and the medicines listed below.
- Adcetris (brentuximab)
- Adriamycin (doxorubicin)
- Adriamycin RDF (doxorubicin)
- Advate (antihemophilic factor)
- Afinitor Disperz (everolimus)
- Avastin (bevacizumab)
- Blenoxane (bleomycin)
- bleomycin
- Corlanor (ivabradine)
- Cosmegen (dactinomycin)
- cyclophosphamide
- Cytoxan (cyclophosphamide)
- Diacomit (stiripentol)
- doxorubicin
- enalapril
- Esbriet (pirfenidone)
- Etopophos (etoposide)
- Exforge HCT (amlodipine / hydrochlorothiazide / valsartan)
- Givlaari (givosiran)
- Hemlibra (emicizumab)
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- Matulane (procarbazine)
- Meticorten (prednisone)
- Mustargen (mechlorethamine)
- Neulasta (pegfilgrastim)
- Ocrevus (ocrelizumab)
- prednisone
- Symdeko (ivacaftor / tezacaftor)
- Thalomid (thalidomide)
Oncovin disease interactions
There are 8 disease interactions with Oncovin (vincristine) which include:
- pulmonary dysfunction
- neurologic dysfunction
- constipation
- hepatic dysfunction
- infections
- myelosuppression
- renal impairment
- SIADH
Report options
More about Oncovin (vincristine)
- Oncovin consumer information
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Rayos
Rayos (prednisone, delayed-release) is used to treat rheumatoid arthritis, polymyalgia rheumatica ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.